CMED is an anti-cancer biotech company. The Beijing based company offers the first non-intrusive method of fighting cancer through ultrasound waves. It seems to be working and thousands of cancer patients from around the world are heading to china for treatment.
Continued.

This is a start up company with small sales now but has a profit of over 50%.
Unheard of in the beginning of a start-up company.
If they expand from profits to world wide franchises this could be a double in two years.
The only problem is the Chineese government controls everything.
As the market dips the stock will go down buy some and hold on.
Buy at 21 then 22 then 23 on the way up and put a stop at the lows seen in Sept.